Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Condition: Mesothelioma Interventions: Drug: Durvalumab / tremelimumab; Drug: Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab Sponsors: Baylor College of Medicine; Duke Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Asbestosis | Cancer & Oncology | Chemotherapy | Mesothelioma | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research